Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of CORAL LAB.. For more details, see the CORAL LAB. quarterly results and CORAL LAB. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.1 |
No. of shares | m | 3.57 |
1 Week | % | -2.0 |
1 Month | % | -4.8 |
1 Year | % | 42.6 |
52 week H/L | Rs | 498.1/225.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
CORAL LAB. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 648 | 381 | 443 | 582 | 368 | |
Low | Rs | 295 | 81 | 95 | 230 | 217 | |
Sales per share (Unadj.) | Rs | 255.1 | 197.7 | 270.5 | 211.8 | 218.8 | |
Earnings per share (Unadj.) | Rs | 28.6 | 20.0 | 38.0 | 25.3 | 18.1 | |
Diluted earnings per share | Rs | 28.6 | 20.0 | 37.9 | 25.3 | 18.0 | |
Cash flow per share (Unadj.) | Rs | 33.9 | 25.6 | 43.5 | 30.9 | 24.2 | |
Dividends per share (Unadj.) | Rs | 2.00 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0.4 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 318.7 | 324.0 | 382.8 | 437.1 | 433.6 | |
Adj. book value per share | Rs | 318.5 | 323.8 | 382.5 | 436.8 | 433.3 | |
Shares outstanding (eoy) | m | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | |
Price / Sales ratio | x | 1.8 | 1.2 | 1.0 | 1.9 | 1.3 | |
Avg P/E ratio | x | 16.5 | 11.6 | 7.1 | 16.0 | 16.2 | |
P/CF ratio (eoy) | x | 13.9 | 9.0 | 6.2 | 13.1 | 12.1 | |
Price / Book Value ratio | x | 1.5 | 0.7 | 0.7 | 0.9 | 0.7 | |
Dividend payout | % | 7.0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 1,685 | 826 | 962 | 1,451 | 1,045 | |
Total wages/salary | Rs m | 98 | 97 | 102 | 112 | 111 |
CORAL LAB. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 911 | 706 | 966 | 756 | 781 | |
Other income | Rs m | 52 | 59 | 38 | 48 | 69 | |
Total revenues | Rs m | 962 | 765 | 1,003 | 804 | 850 | |
Gross profit | Rs m | 124 | 54 | 159 | 92 | 39 | |
Depreciation | Rs m | 19 | 20 | 20 | 20 | 22 | |
Interest | Rs m | 2 | 2 | 0 | 1 | 3 | |
Profit before tax | Rs m | 155 | 91 | 176 | 119 | 82 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 53 | 20 | 41 | 28 | 18 | |
Profit after tax | Rs m | 102 | 71 | 136 | 90 | 64 | |
Gross profit margin | % | 13.6 | 7.7 | 16.4 | 12.1 | 4.9 | |
Effective tax rate | % | 34.1 | 21.8 | 23.0 | 23.7 | 21.6 | |
Net profit margin | % | 11.2 | 10.1 | 14.0 | 12.0 | 8.3 |
CORAL LAB. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 836 | 958 | 1,286 | 1,308 | 1,235 | |
Current liabilities | Rs m | 180 | 251 | 276 | 255 | 119 | |
Net working cap to sales | % | 72.0 | 100.2 | 104.6 | 139.2 | 143.0 | |
Current ratio | x | 4.6 | 3.8 | 4.7 | 5.1 | 10.4 | |
Inventory Days | Days | 120 | 139 | 136 | 267 | 231 | |
Debtors Days | Days | 1,215 | 1,779 | 1,480 | 1,840 | 1,094 | |
Net fixed assets | Rs m | 521 | 485 | 389 | 591 | 508 | |
Share capital | Rs m | 36 | 36 | 36 | 36 | 36 | |
"Free" reserves | Rs m | 1,102 | 1,121 | 1,331 | 1,525 | 1,512 | |
Net worth | Rs m | 1,138 | 1,157 | 1,366 | 1,561 | 1,548 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 1,358 | 1,443 | 1,675 | 1,899 | 1,743 | |
Interest coverage | x | 93.9 | 48.7 | 410.6 | 85.1 | 25.3 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.7 | 0.5 | 0.6 | 0.4 | 0.4 | |
Return on assets | % | 7.6 | 5.1 | 8.1 | 4.8 | 3.9 | |
Return on equity | % | 9.0 | 6.2 | 9.9 | 5.8 | 4.2 | |
Return on capital | % | 13.8 | 8.0 | 12.9 | 7.7 | 5.5 | |
Exports to sales | % | 72.0 | 66.2 | 72.3 | 89.6 | 92.1 | |
Imports to sales | % | 0.6 | 2.9 | 2.0 | 3.5 | 0 | |
Exports (fob) | Rs m | 655 | 467 | 698 | 677 | 719 | |
Imports (cif) | Rs m | 5 | 20 | 19 | 26 | 0 | |
Fx inflow | Rs m | 655 | 467 | 698 | 677 | 719 | |
Fx outflow | Rs m | 18 | 27 | 31 | 39 | 13 | |
Net fx | Rs m | 637 | 441 | 668 | 638 | 706 |
CORAL LAB. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -9 | -39 | 9 | 61 | 127 | |
From Investments | Rs m | 32 | -16 | -1 | -61 | -26 | |
From Financial Activity | Rs m | -12 | 36 | 4 | 1 | -64 | |
Net Cashflow | Rs m | 12 | -19 | 12 | 2 | 36 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
COMP SEC: Ruchi Anjaria | YEAR OF INC: 1997 | BSE CODE: 524506 | FV (Rs): 10 | DIV YIELD (%): - |
Read: CORAL LAB. 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare CORAL LAB. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.